{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06076499",
            "orgStudyIdInfo": {
                "id": "CT-06"
            },
            "organization": {
                "fullName": "Noctrix Health, Inc.",
                "class": "INDUSTRY"
            },
            "briefTitle": "A Post-Market Study for Long-Term Effectiveness and Safety of the NTX100 for RLS",
            "officialTitle": "A Post-Market Observational Clinical Study to Determine the Long-Term Effectiveness and Safety of the Noctrix NTX100 TOMAC (Tonic Motor Activation) System for the Treatment of Restless Legs Syndrome - The THRIVE Study",
            "acronym": "THRIVE",
            "therapeuticArea": [
                "Rare Diseases"
            ],
            "study": "a-post-market-study-for-long-term-effectiveness-and-safety-of-the-for-rls"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-02",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2023-11-15",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2025-06",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2026-12",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2023-09-26",
            "studyFirstSubmitQcDate": "2023-10-06",
            "studyFirstPostDateStruct": {
                "date": "2023-10-10",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-02-20",
            "lastUpdatePostDateStruct": {
                "date": "2024-02-21",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Noctrix Health, Inc.",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": false,
            "isFdaRegulatedDevice": true,
            "isUsExport": false
        },
        "descriptionModule": {
            "briefSummary": "Multi-center post-market, observational study to assess the long-term effectiveness and safety of the NTX100 TOMAC System for patients with Restless Legs Syndrome.",
            "detailedDescription": "This study will assess the NTX100 TOMAC System's long-term effectiveness and safety in real-world settings. Using a prospective, observational approach, we'll monitor individuals receiving the system as part of standard care through five study visits, collecting data on clinical outcomes, device performance, and adverse events."
        },
        "conditionsModule": {
            "conditions": [
                "Restless Legs Syndrome"
            ],
            "keywords": [
                "RLS"
            ]
        },
        "designModule": {
            "studyType": "OBSERVATIONAL",
            "patientRegistry": false,
            "designInfo": {
                "observationalModel": "COHORT",
                "timePerspective": "PROSPECTIVE"
            },
            "enrollmentInfo": {
                "count": 325,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "interventions": [
                {
                    "type": "DEVICE",
                    "name": "NTX100",
                    "description": "NTX100 Tonic Motor Activation (TOMAC) System - a non-invasive peripheral nerve stimulation device programmed to deliver active stimulation."
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Primary Effectiveness Endpoint",
                    "description": "Change from baseline (study entry) in IRLS total score at 1-year.",
                    "timeFrame": "1 year"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "CGI-I score at 1-year relative to baseline",
                    "description": "The 1-year Clinical Global Impression-Improvement (CGI-I) score assesses a patient's overall condition relative to their baseline, indicating treatment effectiveness and change in condition over a year. Scores range from 1 (very much improved) to 7 (very much worse).",
                    "timeFrame": "1 year"
                },
                {
                    "measure": "PGI-I Score at 1-Year Relative to Baseline",
                    "description": "The 1-year Patient Global Impression-Improvement (PGI-I) score assesses the patient's perception of their condition's improvement from baseline, with scores ranging from 1 (very much improved) to 7 (very much worse).",
                    "timeFrame": "1 year"
                },
                {
                    "measure": "Change from baseline in MOS-II total score at 1-year.",
                    "description": "The Medical Outcomes Study 36-Item Short Form Health Survey (MOS-II) measures various aspects of a patient's health-related quality of life. This endpoint assesses the change in the total MOS-II score at the 1-year mark compared to the baseline, and how the treatment impacts overall well-being over the course of a year.",
                    "timeFrame": "1-year"
                },
                {
                    "measure": "Change from Baseline in Frequency of RLS Symptoms (Number of Days per Week) at 1-Year",
                    "description": "This endpoint focuses on Restless Legs Syndrome (RLS) and assesses the change in symptom frequency over a year. It quantifies the reduction in the number of days per week that a patient experiences RLS symptoms, indicating the treatment's effectiveness in managing this condition over time.",
                    "timeFrame": "1-year"
                }
            ],
            "otherOutcomes": [
                {
                    "measure": "CGI-I responder rate, defined as a CGI-I response of \"Very Much Improved\" or \"Much Improved\", at 1-year.",
                    "description": "This metric gauges the proportion of patients showing significant improvement after one year of treatment, defined as a \"Very Much Improved\" or \"Much Improved\" CGI-I response.",
                    "timeFrame": "1-year"
                },
                {
                    "measure": "CGI-I improvement rate, defined as the percentage of patients with a CGI-I response of \"Very Much Improved\", \"Much Improved\" or \"Minimally Improved\".",
                    "description": "This measure indicates the percentage of patients experiencing positive change due to treatment, encompassing \"Very Much Improved,\" \"Much Improved,\" and \"Minimally Improved\" CGI-I responses.",
                    "timeFrame": "1-year"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n1. The subject possesses the necessary equipment, internet/phone accessibility, and communication ability to complete electronic questionnaires and respond to electronic communications and phone calls from the research staff throughout the in-home portion of the study.\n2. The subject has signed a valid, IRB-approved informed consent form, can understand the requirements of the study and instructions for device usage, and can converse in English.\n3. Diagnosis of restless legs syndrome.\n\nExclusion Criteria:\n\n1. The subject has an active medical device implant anywhere in the body (including but not limited to pacemakers, spinal cord stimulators, deep brain stimulators)\n2. The subject has a metal implant at the site of the study device electrode application (not including knee replacements).\n3. The subject has been diagnosed with one of the following conditions:\n\n   \u2022 Epilepsy or other seizure disorder\n4. The subject has a moderate or severe cognitive disorder or mental illness.\n5. The subject has a known allergy to device materials (or a previous severe reaction to medical adhesives or bandages).\n6. Subject has any of the following at or near the location of the device application:\n\n   * Acute injury\n   * Cellulitis\n   * Open sores\n7. The subject is unable or unwilling to comply with study requirements.\n8. The subject is pregnant or trying to become pregnant",
            "sex": "ALL",
            "minimumAge": "21 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ],
            "studyPopulation": "The study population will consist of adults who meet the inclusion and exclusion criteria.",
            "samplingMethod": "PROBABILITY_SAMPLE"
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Jessica Preciado, PhD",
                    "role": "CONTACT",
                    "phone": "5103331437",
                    "email": "jessica@noctrixhealth.com"
                },
                {
                    "name": "Jonathan D Charlesworth, PhD",
                    "role": "CONTACT",
                    "phone": "8046834279",
                    "email": "jcharlesworth@noctrixhealth.com"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Jessica Preciado, PhD",
                    "affiliation": "Noctrix Health, Inc.",
                    "role": "STUDY_DIRECTOR"
                }
            ],
            "locations": [
                {
                    "facility": "Mark J Buchfuhrer, MD Office",
                    "status": "RECRUITING",
                    "city": "Downey",
                    "state": "California",
                    "zip": "90241",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Mark J Buchfuhrer, MD",
                            "role": "CONTACT",
                            "phone": "562-904-1101",
                            "email": "mjbuchfuhrer@gmail.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 33.94001,
                        "lon": -118.13257
                    }
                },
                {
                    "facility": "Sleep Medicine Specialists of California",
                    "status": "RECRUITING",
                    "city": "San Ramon",
                    "state": "California",
                    "zip": "94583",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Haramandeep Singh, MD",
                            "role": "CONTACT",
                            "email": "hsingh@isleepmd.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 37.77993,
                        "lon": -121.97802
                    }
                },
                {
                    "facility": "Southern California Pulmonary and Sleep Disorders Medical Center",
                    "status": "RECRUITING",
                    "city": "Thousand Oaks",
                    "state": "California",
                    "zip": "91361",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Ronald Popper, MD",
                            "role": "CONTACT",
                            "email": "r.popper@sleepmd4u.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 34.17056,
                        "lon": -118.83759
                    }
                },
                {
                    "facility": "Clayton Sleep Institute",
                    "status": "RECRUITING",
                    "city": "Saint Louis",
                    "state": "Missouri",
                    "zip": "63123",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Matthew Uhles, MS",
                            "role": "CONTACT",
                            "email": "UhlesM@claytonsleep.com"
                        },
                        {
                            "name": "Joseph Ojile, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 38.62727,
                        "lon": -90.19789
                    }
                },
                {
                    "facility": "Ohio Sleep Medicine and Institute",
                    "status": "RECRUITING",
                    "city": "Dublin",
                    "state": "Ohio",
                    "zip": "43017",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Rianna West",
                            "role": "CONTACT",
                            "email": "rwest@sleepmedicine.com"
                        },
                        {
                            "name": "Asim Roy, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.09923,
                        "lon": -83.11408
                    }
                },
                {
                    "facility": "Bogan Sleep Consultants, LLC",
                    "status": "RECRUITING",
                    "city": "Columbia",
                    "state": "South Carolina",
                    "zip": "29201",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Heather Byrd",
                            "role": "CONTACT",
                            "email": "Heather.Byrd@bogansleep.com"
                        },
                        {
                            "name": "Richard K Bogan, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 34.00071,
                        "lon": -81.03481
                    }
                }
            ]
        },
        "referencesModule": {
            "references": [
                {
                    "pmid": "33949942",
                    "type": "BACKGROUND",
                    "citation": "Buchfuhrer MJ, Baker FC, Singh H, Kolotovska V, Adlou B, Anand H, de Zambotti M, Ismail M, Raghunathan S, Charlesworth JD. Noninvasive neuromodulation reduces symptoms of restless legs syndrome. J Clin Sleep Med. 2021 Aug 1;17(8):1685-1694. doi: 10.5664/jcsm.9404."
                },
                {
                    "pmid": "36856064",
                    "type": "BACKGROUND",
                    "citation": "Charlesworth JD, Adlou B, Singh H, Buchfuhrer MJ. Bilateral high-frequency noninvasive peroneal nerve stimulation evokes tonic leg muscle activation for sleep-compatible reduction of restless legs syndrome symptoms. J Clin Sleep Med. 2023 Jul 1;19(7):1199-1209. doi: 10.5664/jcsm.10536."
                },
                {
                    "pmid": "37458698",
                    "type": "BACKGROUND",
                    "citation": "Bogan RK, Roy A, Kram J, Ojile J, Rosenberg R, Hudson JD, Scheuller HS, Winkelman JW, Charlesworth JD. Efficacy and safety of tonic motor activation (TOMAC) for medication-refractory restless legs syndrome: a randomized clinical trial. Sleep. 2023 Oct 11;46(10):zsad190. doi: 10.1093/sleep/zsad190."
                },
                {
                    "pmid": "37439365",
                    "type": "BACKGROUND",
                    "citation": "Roy A, Ojile J, Kram J, Olin J, Rosenberg R, Hudson JD, Bogan RK, Charlesworth JD. Long-term efficacy and safety of tonic motor activation for treatment of medication-refractory restless legs syndrome: A 24-Week Open-Label Extension Study. Sleep. 2023 Oct 11;46(10):zsad188. doi: 10.1093/sleep/zsad188."
                }
            ],
            "seeAlsoLinks": [
                {
                    "label": "Noninvasive neuromodulation reduces symptoms of restless legs syndrome",
                    "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8656897/"
                },
                {
                    "label": "Bilateral high-frequency noninvasive peroneal nerve stimulation evokes tonic leg muscle activation for sleep-compatible reduction of restless legs syndrome symptoms",
                    "url": "https://pubmed.ncbi.nlm.nih.gov/36856064/"
                },
                {
                    "label": "Efficacy and safety of tonic motor activation (TOMAC) for medication-refractory restless legs syndrome: a randomized clinical tria",
                    "url": "https://doi.org/10.1093/sleep/zsad190"
                },
                {
                    "label": "Long-term efficacy and safety of tonic motor activation for treatment of medication-refractory restless legs syndrome",
                    "url": "https://doi.org/10.1093/sleep/zsad188"
                }
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000011595",
                    "term": "Psychomotor Agitation"
                },
                {
                    "id": "D000012148",
                    "term": "Restless Legs Syndrome"
                },
                {
                    "id": "D000013577",
                    "term": "Syndrome"
                }
            ],
            "ancestors": [
                {
                    "id": "D000004194",
                    "term": "Disease"
                },
                {
                    "id": "D000010335",
                    "term": "Pathologic Processes"
                },
                {
                    "id": "D000020820",
                    "term": "Dyskinesias"
                },
                {
                    "id": "D000009461",
                    "term": "Neurologic Manifestations"
                },
                {
                    "id": "D000009422",
                    "term": "Nervous System Diseases"
                },
                {
                    "id": "D000011596",
                    "term": "Psychomotor Disorders"
                },
                {
                    "id": "D000019954",
                    "term": "Neurobehavioral Manifestations"
                },
                {
                    "id": "D000096762",
                    "term": "Aberrant Motor Behavior in Dementia"
                },
                {
                    "id": "D000001526",
                    "term": "Behavioral Symptoms"
                },
                {
                    "id": "D000020919",
                    "term": "Sleep Disorders, Intrinsic"
                },
                {
                    "id": "D000020920",
                    "term": "Dyssomnias"
                },
                {
                    "id": "D000012893",
                    "term": "Sleep Wake Disorders"
                },
                {
                    "id": "D000020447",
                    "term": "Parasomnias"
                },
                {
                    "id": "D000001523",
                    "term": "Mental Disorders"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M16355",
                    "name": "Syndrome",
                    "asFound": "Syndrome",
                    "relevance": "HIGH"
                },
                {
                    "id": "M14452",
                    "name": "Psychomotor Agitation",
                    "asFound": "Restless",
                    "relevance": "HIGH"
                },
                {
                    "id": "M14984",
                    "name": "Restless Legs Syndrome",
                    "asFound": "Restless Legs Syndrome",
                    "relevance": "HIGH"
                },
                {
                    "id": "M22574",
                    "name": "Dyskinesias",
                    "relevance": "LOW"
                },
                {
                    "id": "M12404",
                    "name": "Neurologic Manifestations",
                    "relevance": "LOW"
                },
                {
                    "id": "M14453",
                    "name": "Psychomotor Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M21826",
                    "name": "Neurobehavioral Manifestations",
                    "relevance": "LOW"
                },
                {
                    "id": "M6904",
                    "name": "Dementia",
                    "relevance": "LOW"
                },
                {
                    "id": "M3259",
                    "name": "Aberrant Motor Behavior in Dementia",
                    "relevance": "LOW"
                },
                {
                    "id": "M4818",
                    "name": "Behavioral Symptoms",
                    "relevance": "LOW"
                },
                {
                    "id": "M22242",
                    "name": "Parasomnias",
                    "relevance": "LOW"
                },
                {
                    "id": "M22654",
                    "name": "Sleep Disorders, Intrinsic",
                    "relevance": "LOW"
                },
                {
                    "id": "M22655",
                    "name": "Dyssomnias",
                    "relevance": "LOW"
                },
                {
                    "id": "M15696",
                    "name": "Sleep Wake Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M4815",
                    "name": "Mental Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M14473",
                    "name": "Psychotic Disorders",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC10",
                    "name": "Nervous System Diseases"
                },
                {
                    "abbrev": "BXM",
                    "name": "Behaviors and Mental Disorders"
                }
            ]
        },
        "interventionBrowseModule": {
            "browseLeaves": [
                {
                    "id": "M12478",
                    "name": "Nicotine",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}